Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt
· Delayed Price · Currency is EGP 797.24
-8.64 (-1.07%)
At close: Mar 8, 2026
EGX:AXPH Ratios and Metrics
Market cap in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 3,986 | 2,228 | 1,054 | 691 | 529 | 675 | Upgrade
|
| Market Cap Growth | 102.09% | 111.49% | 52.48% | 30.54% | -21.61% | 6.68% | Upgrade
|
| Enterprise Value | 3,744 | 2,058 | 916 | 546 | 489 | 612 | Upgrade
|
| Last Close Price | 797.24 | 414.37 | 177.60 | 107.31 | 74.62 | 88.99 | Upgrade
|
| PE Ratio | 8.07 | 5.70 | 4.86 | 5.47 | 4.51 | 5.77 | Upgrade
|
| Forward PE | - | 4.57 | 4.57 | 4.57 | 4.57 | 4.30 | Upgrade
|
| PS Ratio | 1.32 | 0.81 | 0.60 | 0.47 | 0.48 | 0.61 | Upgrade
|
| PB Ratio | 4.23 | 2.24 | 1.33 | 1.05 | 0.86 | 1.15 | Upgrade
|
| P/TBV Ratio | 4.23 | 2.24 | 1.33 | 1.05 | 0.86 | 1.15 | Upgrade
|
| P/FCF Ratio | 13.65 | 7.28 | 8.27 | 97.40 | 3.29 | - | Upgrade
|
| P/OCF Ratio | 11.77 | 6.63 | 5.56 | 7.57 | 2.75 | 6.79 | Upgrade
|
| EV/Sales Ratio | 1.24 | 0.75 | 0.52 | 0.37 | 0.45 | 0.55 | Upgrade
|
| EV/EBITDA Ratio | 5.57 | 3.76 | 3.00 | 2.99 | 3.10 | 3.44 | Upgrade
|
| EV/EBIT Ratio | 5.99 | 4.08 | 3.43 | 3.53 | 3.64 | 3.97 | Upgrade
|
| EV/FCF Ratio | 12.82 | 6.72 | 7.19 | 77.01 | 3.04 | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.01 | 0.00 | 0.07 | 0.06 | 0.01 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.01 | 0.01 | 1.70 | 0.06 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.26 | -0.28 | -0.19 | -0.12 | -0.24 | -0.09 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.36 | -0.51 | -0.49 | -0.43 | -0.92 | -0.28 | Upgrade
|
| Net Debt / FCF Ratio | -0.83 | -0.92 | -1.17 | -11.06 | -0.90 | 2.45 | Upgrade
|
| Asset Turnover | 2.06 | 1.99 | 1.63 | 1.65 | 1.32 | 1.38 | Upgrade
|
| Inventory Turnover | 4.29 | 3.70 | 3.16 | 3.97 | 3.03 | 2.91 | Upgrade
|
| Quick Ratio | 0.85 | 0.96 | 0.69 | 0.75 | 1.15 | 0.93 | Upgrade
|
| Current Ratio | 1.78 | 2.21 | 1.97 | 2.34 | 2.35 | 2.64 | Upgrade
|
| Return on Equity (ROE) | 59.51% | 43.72% | 29.78% | 19.87% | 19.59% | 20.20% | Upgrade
|
| Return on Assets (ROA) | 26.60% | 22.79% | 15.45% | 10.77% | 10.08% | 12.07% | Upgrade
|
| Return on Invested Capital (ROIC) | 71.00% | 57.12% | 33.49% | 22.63% | 21.93% | 25.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 65.70% | 50.30% | 33.20% | 23.00% | 21.60% | 26.00% | Upgrade
|
| Earnings Yield | 12.39% | 17.55% | 20.57% | 18.30% | 22.18% | 17.33% | Upgrade
|
| FCF Yield | 7.33% | 13.74% | 12.09% | 1.03% | 30.40% | -3.05% | Upgrade
|
| Dividend Yield | 7.90% | 15.19% | 16.89% | 12.11% | - | 11.24% | Upgrade
|
| Payout Ratio | 57.70% | 44.40% | 37.83% | 60.86% | 54.95% | 85.72% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | - | 15.35% | Upgrade
|
| Total Shareholder Return | 7.81% | 15.19% | 16.89% | 12.11% | - | 26.58% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.